CORLICYTE
Live / Registered — Registered (as of 10 Mar 2020)
What this means for you
Registered since 10 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87104861
- Registration number
- 6008207
- Mark type
- Stylized text
- Filed
- 15 Jul 2016
- Published for opposition
- 06 Dec 2016
- Registered
- 10 Mar 2020
- Attorney of record
- Michael Whittaker
Goods and services
- Class 005 — Pharmaceuticals: Cord lining stem cells for medical and veterinary purposes, namely, for treating wounds, eczema, skin diseases, atopic dermatitis, arthritic diseases, cardiac diseases, corneal diseases, liver diseases, genetic diseases, neuronal diseases, bone diseases, and cartilage diseases; Pharmaceutical and veterinary preparations containing cord lining stem cells for treating wounds, eczema, skin diseases, atopic dermatitis, arthritic diseases, cardiac diseases, corneal diseases, liver diseases, genetic diseases, neuronal diseases, bone diseases, and cartilage diseases
Owner
- CellResearch Corporation Pte Ltd., Singapore, SG
- CellResearch Corporation Pte Ltd., Singapore, SG
- CellResearch Corporation Pte Ltd., Singapore, SG
Prosecution history
- 10 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 04 Feb 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Feb 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Feb 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Jan 2020 — USE AMENDMENT FILED
- 31 Jan 2020 — TEAS STATEMENT OF USE RECEIVED
- 23 Jul 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2019 — SOU EXTENSION 5 GRANTED
- 17 Jul 2019 — SOU EXTENSION 5 FILED
- 22 Jul 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Jul 2019 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jan 2019 — SOU EXTENSION 4 GRANTED
- 29 Jan 2019 — SOU EXTENSION 4 FILED